Endo Health Solutions (NASDAQ:ENDP) had its price target increased by Stifel Nicolaus from $40.00 to $60.00 in a research report sent to investors on Wednesday morning, American Banking & Market News reports. The firm currently has a buy rating on the stock.
Other equities research analysts have also recently issued reports about the stock. Analysts at Janney Montgomery Scott upgraded shares of Endo Health Solutions from a sell rating to a neutral rating in a research note to investors on Wednesday. Separately, analysts at Cantor Fitzgerald upgraded shares of Endo Health Solutions from a sell rating to a hold rating in a research note to investors on Wednesday. They now have a $54.00 price target on the stock, up previously from $30.00. Finally, analysts at Piper Jaffray Cos. upgraded shares of Endo Health Solutions from an underweight rating to a neutral rating in a research note to investors on Wednesday. They now have a $58.00 price target on the stock, up previously from $26.00. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and ten have assigned a buy rating to the company. Endo Health Solutions presently has a consensus rating of Hold and an average target price of $47.81.
Shares of Endo Health Solutions (NASDAQ:ENDP) opened at 58.55 on Wednesday. Endo Health Solutions has a 52-week low of $25.01 and a 52-week high of $58.23. The stock has a 50-day moving average of $45.99 and a 200-day moving average of $40.10. The company’s market cap is $6.687 billion.
Endo Health Solutions (NASDAQ:ENDP) last posted its quarterly earnings results on Thursday, November 7th. The company reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.23. The company had revenue of $715.00 million for the quarter, compared to the consensus estimate of $695.63 million. During the same quarter in the prior year, the company posted $1.28 earnings per share. The company’s quarterly revenue was down 4.7% on a year-over-year basis. On average, analysts predict that Endo Health Solutions will post $4.73 earnings per share for the current fiscal year.
Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.